Circular Genomics
Genomics & Genetic Testing · Health Care
$23.3Mtotal raised · 3 rounds on record
$15Mlatest round · Series A · Dec 2025 · 11 mo ago
2backers · Cottonwood Technology Fund, Ingenuityvc
50+team · employees, estimated range
Overview
Advancing precision neurology through brain-derived circular RNA, blood-based biomarkers, and molecular intelligence for neuroscience research.
Funding and backers
Total raised
$23.3M
3 rounds on record
Latest round
$15M
Series A · Dec 2025 · 11 mo ago
Team
51-200
employees, estimated range
Backers
2
Cottonwood Technology Fund, Ingenuityvc
The money's age
Fresh money
11 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 2
Launched Circular Genomics Unveils Its CircPATH Platform Following Landmark Nature Medicine Study Demonstrating Breakthrough Performance in Early Detection of… · PRNewswire
Dec 1, 2025
Raised a round Series A $15M
Dec 1, 2025
Shut down Circular Genomics Announces Closure of $15 Million Series A Financing to Advance First-in-Class Circular RNA Platform for Early Detection of Alzheimer · PRNewswire
Jan 11, 2024
Raised a round Venture round $8.3M · SEC Form D
Aug 5, 2021
Took on debt financing $3.1M · SEC Form D
2021
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series A | Dec 2025 | $15M | — | tramwayventures.com |
| Venture round | Jan 2024 | $8.3M | — | SEC Form D |
| Debt Financing | Aug 2021 | $3.1M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | CircularGenomics, Inc. | its site |
Founders and leadersfrom filings, registers and the company's site
Alexander HafezExecutive Officer, DirectorSEC Form D
Nikolaos MelliosDirectorSEC Form D
Stephen McKernanExecutive OfficerSEC Form D
Paul SargeantExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
ゲノム （ DNA ）、エピゲノム、トランスクリプトーム （ RNA ）を独自の技術で解析し、研究開発の効率・精度を格段に向上させます。次世代シーケンス（ NGS ）／ エピジェネティクス 研究の 実験デザイン から 情報 解析、論文化、事業化までオーダーメイドで支援します。.
Phenomix Sciences uses AI for precision obesity medicine integrating genetic, clinical, and biomarker data. Deliver the right intervention…
ChromaCode is a leading provider of HDPCR™ multiplexing technology for genomic solutions. Our breakthrough platform enables labs…
IconPCR with AutoNorm gives you normalized, sequencing-ready NGS libraries in one step, with real-time per-well control for 16S…
The RNA Platform Powering the Next Wave of Precision Medicine Using full-length RNA sequencing from blood to detect novel biomarkers that…
Precede Biosciences is a precision diagnostics and data company redefining what can be learned from a simple blood draw.
People
Alexander Hafez
Executive Officer, Director
Nikolaos Mellios
Director
Stephen McKernan
Executive Officer
Paul Sargeant
Executive Officer, Director
Kosmas Karadimitriou
Director
Cathy Petti
Director
Waneta Tuttle
Director
Joseph Cook III
Director
Blivin David
Director
Fortunado Rocca
Director
David Blivin
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
IngenuityvcVia a fund
Cottonwood Technology FundVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Circular Genomics Unveils Its CircPATH Platform Following Landmark Nature Medicine Study Demonstrating Breakthrough Performance in Early Detection of Alzheimer
Blood-Based Circular RNA Biomarkers Outperform Gold-Standard Tests, Enable Preclinical Risk Stratification Years Before Symptom Onset, and Open New Era in...
Read more
Report
Circular Genomics Announces Closure of $15 Million Series A Financing to Advance First-in-Class Circular RNA Platform for Early Detection of Alzheimer
/PRNewswire/ -- Circular Genomics, Inc., the world-leading developer of circular RNA-based precision medicine tools for neurology and psychiatry, today...
Read more
Report
Precision Medicine in Mental Health Company, Circular Genomics, Appoints, Dr. Paul Sargeant as Chief Executive Officer
/PRNewswire/ -- Circular Genomics, the leading company in developing circular RNA-based precision medicine tools, data and diagnostics for neurology and...
Read more
Report
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Albuquerque
United States
HQ
San Diego
United States
HQ
Help Advance the Future of Brain Health
10935 Alexandria Way, Suite 201, San Diego, CA 92121